Abstract
Bone is constantly being remodeled to ensure development and maintenance of a healthy skeletal system. Normal bone remodeling is dependent upon several factors. Bone remodeling is under the auspices of osteoclasts which cause bone resorption, and osteoblasts which stimulate bone formation. This interplay between osteoclasts and osteoblasts is under a system of checks and balances through a complex signaling cascade that ensures healthy bone formation. Disruption of this signaling cascade can lead to abnormal bone remodeling and ultimately result in diseased bones. This can occur in a variety of manners that will be elaborated on in this chapter.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Referecnes
Feng X, McDonald JM. Disorders of bone remodeling. Annu Rev Pathol. 2011;6:121–45.
Moe S, et al. Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2006;69(11):1945–53.
KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl. 2009(113):S1–130.
Hruska KA, Teitelbaum SL. Renal osteodystrophy. N Engl J Med. 1995;333(3):166–74.
Wu CC, et al. Diagnosis and management of osteopetrosis: consensus guidelines from the osteopetrosis working group. J Clin Endocrinol Metab. 2017;102(9):3111–23.
Tolar J, Teitelbaum SL, Orchard PJ. Osteopetrosis. N Engl J Med. 2004;351(27):2839–49.
Garrett G, et al. PTH--a particularly tricky hormone: why measure it at all in kidney patients? Clin J Am Soc Nephrol. 2013;8(2):299–312.
Patel AA, et al. Imaging findings and evaluation of metabolic bone disease. Adv Radiol. 2015;2015:21.
Miller PD. Chronic kidney disease and osteoporosis: evaluation and management. BoneKEy Rep. 2014;3:542.
Carvalho C, Alves CM, Frazao JM. The role of bone biopsy for the diagnosis of renal osteodystrophy: a short overview and future perspectives. J Nephrol. 2016;29(5):617–26.
Miller PD, et al. Teriparatide in postmenopausal women with osteoporosis and mild or moderate renal impairment. Osteoporos Int. 2007;18(1):59–68.
van Staa TP, et al. Incidence and natural history of Paget’s disease of bone in England and Wales. J Bone Miner Res. 2002;17(3):465–71.
Singer FR, et al. Paget’s disease of bone: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014;99(12):4408–22.
Eekhoff ME, et al. Paget’s disease of bone in The Netherlands: a population-based radiological and biochemical survey--the Rotterdam Study. J Bone Miner Res. 2004;19(4):566–70.
Ralston SH, Langston AL, Reid IR. Pathogenesis and management of Paget’s disease of bone. Lancet. 2008;372(9633):155–63.
Siris ES, et al. Medical management of Paget’s disease of bone: indications for treatment and review of current therapies. J Bone Miner Res. 2006;21(Suppl 2):P94–8.
Corral-Gudino L, et al. Bisphosphonates for Paget’s disease of bone in adults. Cochrane Database Syst Rev. 2017;12:Cd004956.
Muschitz C, et al. Diagnosis and treatment of Paget’s disease of bone: a clinical practice guideline. Wien Med Wochenschr. 2017;167(1–2):18–24.
Merlotti D, et al. Comparison of different intravenous bisphosphonate regimens for Paget’s disease of bone. J Bone Miner Res. 2007;22(10):1510–7.
Wootton R, et al. Skeletal blood flow in Paget’s disease of bone and its response to calcitonin therapy. Clin Sci Mol Med. 1978;54(1):69–74.
Reid IR, et al. Treatment of Paget’s disease of bone with Denosumab: case report and literature review. Calcif Tissue Int. 2016;99(3):322–5.
Schwarz P, et al. Paget’s disease of the bone after treatment with Denosumab: a case report. Bone. 2012;50(5):1023–5.
Seehra J, Sloan P, Oliver RJ. Paget’s disease of bone and osteonecrosis. Dent Update. 2009;36(3):166–8, 171–2
Wat WZ. Current perspectives on bisphosphonate treatment in Paget’s disease of bone. Ther Clin Risk Manag. 2014;10:977–83.
Khan AA, et al. Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus. J Bone Miner Res. 2015;30(1):3–23.
Wermers RA, et al. Morbidity and mortality associated with Paget’s disease of bone: a population-based study. J Bone Miner Res. 2008;23(6):819–25.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Harty, R., Jones, M.S. (2021). Principles of Diagnosis and Treatment of Bone Remodeling Disorders. In: Esther, R.J. (eds) Clinical Foundations of Musculoskeletal Medicine. Springer, Cham. https://doi.org/10.1007/978-3-030-42894-5_5
Download citation
DOI: https://doi.org/10.1007/978-3-030-42894-5_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-42893-8
Online ISBN: 978-3-030-42894-5
eBook Packages: MedicineMedicine (R0)